Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-06-28 Purchase |
2024-07-01 4:27 pm |
DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEnterprise Private AB 10% Owner |
1,200,000 | $2.5 | $3,000,000 | 5,526,435 (Indirect) |
View |
2024-06-28 Purchase |
2024-07-01 4:24 pm |
DiaMedica Therapeutics Inc. | DMAC | STAHLBERG JAN TRILL AB 10% Owner |
1,200,000 | $2.5 | $3,000,000 | 5,221,608 (Indirect) |
View |
2023-11-16 Purchase |
2023-11-16 4:37 pm |
DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer |
20,000 | $2.46 | $49,200 | 527,114 (Direct) |
View |
2023-06-23 Purchase |
2023-06-27 4:11 pm |
DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEqt Private AB 10% Owner |
1,470,588 | $3.4 | $4,999,999 | 4,326,435 (Indirect) |
View |
2023-06-23 Purchase |
2023-06-26 4:42 pm |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
65,000 | $3.91 | $254,150 | 391,998 (Indirect Direct) |
View |
2023-06-23 Purchase |
2023-06-26 4:34 pm |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
12,787 | $3.91 | $49,997 | 68,591 (Direct) |
View |
2023-06-23 Purchase |
2023-06-26 4:26 pm |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
12,787 | $3.91 | $49,997 | 29,943 (Direct) |
View |
2023-06-23 Purchase |
2023-06-26 4:21 pm |
DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary |
10,000 | $3.91 | $39,100 | 32,290 (Direct) |
View |
2023-06-23 Purchase |
2023-06-26 4:14 pm |
DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer |
38,364 | $3.91 | $150,003 | 507,114 (Direct) |
View |
2023-06-23 Purchase |
2023-06-26 4:03 pm |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
38,363 | $3.91 | $149,999 | 248,245 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-07 Exercise |
2025-04-08 4:41 pm |
N/A 2025-12-01 |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
24,000 | $0 | 312,995 (Direct) |
View |
2025-04-07 Exercise |
2025-04-08 4:41 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
24,000 | $2.11 | 312,995 (Direct) |
View |
2025-02-20 Option Award |
2025-02-24 5:06 pm |
N/A 2035-02-19 |
DiaMedica Therapeutics Inc. | DMAC | O'Connor Daniel J. Director |
64,242 | $0 | 64,242 (Direct) |
View |
2025-02-13 Exercise |
2025-02-18 4:25 pm |
N/A 2025-12-01 |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
17,000 | $0 | 439,055 (Direct) |
View |
2025-02-13 Exercise |
2025-02-18 4:25 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
5,000 | $3.65 | 439,055 (Direct) |
View |
2025-02-13 Exercise |
2025-02-18 4:25 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
12,000 | $2.11 | 439,055 (Direct) |
View |
2025-01-02 Option Award |
2025-01-03 4:46 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
15,917 | $5.34 | 80,141 (Direct) |
View |
2025-01-02 Option Award |
2025-01-03 4:46 pm |
N/A 2035-01-01 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
4,287 | $0 | 80,141 (Direct) |
View |
2025-01-02 Option Award |
2025-01-03 4:36 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
10,861 | $5.34 | 422,055 (Direct) |
View |
2025-01-02 Option Award |
2025-01-03 4:28 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Kuntz Richard Director |
9,925 | $5.34 | 24,210 (Direct) |
View |
2025-01-02 Option Award |
2025-01-03 4:23 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
10,393 | $5.34 | 288,995 (Direct) |
View |
2025-01-02 Option Award |
2025-01-03 4:15 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
5,290 | $5.34 | 44,608 (Direct) |
View |
2024-06-01 Option Award |
2024-06-03 5:06 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer |
130,000 | $0 | 657,114 (Direct) |
View |
2024-06-01 Option Award |
2024-06-03 4:59 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary |
130,000 | $0 | 162,290 (Direct) |
View |
2024-06-01 Option Award |
2024-06-03 4:58 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Cundari Dominic R Chief Commercial Officer |
15,000 | $0 | 17,800 (Direct) |
View |
2024-06-01 Option Award |
2024-06-03 4:41 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
300,000 | $0 | 368,591 (Direct) |
View |
2024-06-01 Option Award |
2024-06-03 4:35 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
28,472 | $0 | 67,790 (Direct) |
View |
2024-06-01 Option Award |
2024-06-03 4:29 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
36,065 | $0 | 314,667 (Direct) |
View |
2024-06-01 Option Award |
2024-06-03 4:21 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
28,472 | $0 | 88,409 (Direct) |
View |
2024-06-01 Option Award |
2024-06-03 4:14 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director |
28,472 | $0 | 28,472 (Direct) |
View |
2024-06-01 Option Award |
2024-06-03 4:09 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Kuntz Richard Director |
28,472 | $0 | 42,757 (Direct) |
View |
2024-06-01 Option Award |
2024-06-03 4:02 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
28,472 | $0 | 439,666 (Direct) |
View |
2024-01-22 Option Award |
2024-01-23 4:23 pm |
N/A 2034-01-21 |
DiaMedica Therapeutics Inc. | DMAC | Lorianne Masuoka K. Chief Medical Officer |
285,000 | $0 | 285,000 (Direct) |
View |
2024-01-02 Option Award |
2024-01-02 5:05 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
9,375 | $2.8 | 39,318 (Direct) |
View |
2024-01-02 Option Award |
2024-01-02 5:00 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Kuntz Richard Director |
14,285 | $2.8 | 14,285 (Direct) |
View |
2024-01-02 Option Award |
2024-01-02 4:47 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
30,357 | $2.8 | 278,602 (Direct) |
View |
2024-01-02 Option Award |
2024-01-02 4:39 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
21,428 | $2.8 | 59,937 (Direct) |
View |
2024-01-02 Option Award |
2024-01-02 4:30 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
19,196 | $2.8 | 411,194 (Direct) |
View |
Ownership |
2023-06-27 4:10 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | STAHLBERG JAN TRILL AB 10% Owner |
0 | $0 | 4,021,608 (Indirect) |
View |
2023-06-23 Gift |
2023-06-26 4:42 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
15,000 | $0 | 391,998 (Direct) |
View |
Ownership |
2023-06-23 5:10 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | JACINTO RICHARD II 10% Owner |
0 | $0 | 4,558,823 (Indirect) |
View |
2023-06-01 Option Award |
2023-06-02 5:16 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Daves Julie VanOrsdel SVP Clinical Development Oper. |
54,000 | $0 | 54,000 (Direct) |
View |
2023-06-01 Option Award |
2023-06-02 5:01 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Cundari Dominic R Chief Commercial Officer |
27,000 | $0 | 29,800 (Direct) |
View |